According to Gram Research analysis, a peptide called NW-9 found in Jinhua ham reduced liver damage markers by 50-54% and decreased inflammation signals by 15-34% in laboratory tests. The peptide appears to work by calming a cellular inflammation pathway called cGAS-STING. However, these findings are preliminary—conducted in cells and animals, not humans—so more research is needed before this compound can be recommended as a liver health treatment.
Researchers discovered that a special protein fragment found in Jinhua ham—a traditional Chinese meat product—may help protect the liver and reduce inflammation. In laboratory tests, this peptide called NW-9 reduced harmful liver enzymes by about 50% and decreased inflammatory markers significantly. The study used advanced computer modeling and animal testing to understand how this peptide works by blocking a specific inflammation pathway in the body. These findings suggest that traditional foods like Jinhua ham could be developed into functional foods that support liver health, though more human studies are needed to confirm the benefits.
Key Statistics
A 2026 research article published in the Journal of Agricultural and Food Chemistry found that the peptide NW-9 from Jinhua ham reduced liver enzyme AST by 51.66% and ALT by 54.08% in laboratory cell cultures.
According to the same 2026 study, NW-9 decreased inflammatory markers IL-1β by 24.66%, IL-6 by 33.71%, and TNF-α by 15.79%, suggesting significant anti-inflammatory effects in laboratory conditions.
Gram Research analysis of this 2026 study shows that NW-9 works by targeting the cGAS-STING inflammation pathway, which is involved in nonalcoholic fatty liver disease development.
The Quick Take
- What they studied: Whether special protein pieces (peptides) found in Jinhua ham could protect the liver and reduce inflammation in the body
- Who participated: Laboratory cell cultures and animal models; no human participants were involved in this study
- Key finding: A peptide called NW-9 reduced liver damage markers by 50-54% and decreased inflammation signals by 15-34% in laboratory conditions
- What it means for you: This research suggests Jinhua ham contains compounds that might help protect liver health, but these findings are preliminary and haven’t been tested in humans yet. Don’t rely on ham alone for liver health—consult your doctor about proven strategies
The Research Details
Scientists used a multi-step approach to find and test special protein fragments in Jinhua ham. First, they used mass spectrometry (a tool that identifies molecules) and computer modeling to predict which peptides might help the liver. Then they used molecular docking—imagine fitting puzzle pieces together on a computer—to see how these peptides would interact with inflammation pathways in cells. Finally, they tested the most promising peptide (called NW-9) in laboratory cell cultures and in animal models to see if it actually worked.
The researchers focused on a specific inflammation pathway called cGAS-STING, which is involved in liver disease. They measured several markers of liver damage (enzymes called AST and ALT) and inflammation signals (IL-1β, IL-6, and TNF-α) to determine if NW-9 could reduce them.
This approach combines computer prediction with real-world testing, which helps researchers identify promising compounds before moving to human studies. The use of both laboratory cells and animal models provides evidence from different biological systems.
This research matters because nonalcoholic fatty liver disease affects millions of people worldwide and current treatment options are limited. By studying traditional foods like Jinhua ham, researchers can discover natural compounds that might help prevent or treat liver disease. This approach is valuable because it combines ancient food traditions with modern science, potentially creating new functional foods that support health.
This study demonstrates solid scientific methodology by combining computational prediction with laboratory and animal testing. However, important limitations exist: the study was conducted in laboratory conditions and animals, not humans. The sample size for animal studies wasn’t specified. The research is preliminary and represents early-stage discovery. Results in cells and animals don’t always translate to humans, so human clinical trials would be needed to confirm these benefits. The study was published in a peer-reviewed journal, which adds credibility, but the findings should be considered preliminary until replicated in human studies.
What the Results Show
The peptide NW-9 showed impressive results in laboratory tests. At a concentration of 1 mg/mL, it reduced AST (a liver enzyme) by 51.66% and ALT (another liver enzyme) by 54.08%. These enzymes are markers of liver damage, so their reduction suggests the peptide protected liver cells from injury.
The peptide also reduced inflammatory signals in the body. It decreased IL-1β by 24.66%, IL-6 by 33.71%, and TNF-α by 15.79%. These are chemical messengers that trigger inflammation, so reducing them means less inflammation in the body. In animal studies, NW-9 also showed therapeutic effects, meaning it actually helped improve liver health.
The mechanism behind these benefits appears to involve the cGAS-STING pathway, which is a cellular alarm system that triggers inflammation. NW-9 appears to calm this alarm system, reducing the inflammatory response that damages the liver. This is particularly relevant for nonalcoholic fatty liver disease, where excessive inflammation plays a major role in disease progression.
The research demonstrated that traditional food products like Jinhua ham contain bioactive compounds with multiple health benefits. The dual-function nature of NW-9—meaning it both reduces inflammation and protects the liver—makes it particularly valuable. The study also showed that computational modeling combined with laboratory testing is an effective approach for discovering new bioactive compounds from food sources. This methodology could be applied to other traditional foods to identify additional health-promoting peptides.
This research builds on growing evidence that food-derived peptides have health benefits. Previous studies have shown that peptides from various protein sources can have anti-inflammatory effects, but this study is notable for identifying a specific peptide from Jinhua ham with dual benefits and characterizing its mechanism of action through the cGAS-STING pathway. The focus on this specific pathway represents a more detailed understanding of how food peptides might work compared to earlier research that simply documented anti-inflammatory effects without explaining the mechanism.
This study has several important limitations. First, all testing was conducted in laboratory conditions (cell cultures) and animal models—no human studies were performed. Results in animals don’t always translate to humans due to differences in metabolism and physiology. Second, the specific sample sizes for animal studies weren’t clearly reported, making it difficult to assess statistical power. Third, the study doesn’t address how much Jinhua ham a person would need to eat to achieve these benefits, or whether the peptide survives digestion when consumed as food. Fourth, the research doesn’t compare NW-9 to existing liver disease treatments. Finally, long-term safety and effectiveness in humans remain unknown. These limitations mean the findings are preliminary and should not be used as medical advice without further human research.
The Bottom Line
Based on this preliminary research, there is insufficient evidence to recommend Jinhua ham specifically as a liver disease treatment. However, the findings suggest that including diverse protein sources like traditional meat products in a balanced diet may have health benefits. For people with liver disease or at risk for fatty liver disease, consult a healthcare provider about proven interventions including weight management, reduced alcohol consumption, and regular exercise. This research should be viewed as early-stage discovery that may eventually lead to functional food products, but such products don’t yet exist for consumers.
This research is most relevant to: (1) people with nonalcoholic fatty liver disease or at risk for it, (2) food scientists and functional food developers, (3) researchers studying bioactive compounds in traditional foods, and (4) people interested in how traditional foods might support health. People should NOT use this as a reason to dramatically increase ham consumption, as processed meats have other health considerations. Healthcare providers treating liver disease should note this as emerging research but not yet as a treatment option.
If these findings eventually lead to human studies and approved functional foods, benefits would likely take weeks to months to become apparent, similar to other dietary interventions. However, this is speculative—human clinical trials would need to be conducted first, which typically takes several years. Don’t expect immediate results from dietary changes based on this preliminary research.
Frequently Asked Questions
Can eating Jinhua ham help protect my liver?
This 2026 research shows promise in laboratory tests, but human studies haven’t been conducted yet. Eating more ham isn’t recommended without consulting your doctor, as processed meats have other health considerations. Focus on proven liver-protective strategies like maintaining healthy weight and limiting alcohol.
What is the NW-9 peptide and how does it work?
NW-9 is a protein fragment identified in Jinhua ham that appears to reduce liver inflammation by calming the cGAS-STING pathway—a cellular alarm system. In laboratory tests, it reduced liver damage markers by about 50% and inflammatory signals by 15-34%, but human testing is needed.
Is this research ready to be used as a treatment for fatty liver disease?
No. This is early-stage research conducted in laboratory cells and animals only. Functional food products based on these findings don’t yet exist for consumers. Anyone with liver disease should work with their healthcare provider on proven treatments while this research continues.
How long until products based on this research will be available?
That’s uncertain. The research must first proceed through human clinical trials, which typically take several years. Even if successful, regulatory approval and product development would take additional time. This is preliminary discovery, not an imminent product launch.
What should I do if I have nonalcoholic fatty liver disease?
Consult your healthcare provider about proven interventions: weight management, regular exercise, reduced alcohol consumption, and dietary improvements. Monitor liver enzyme levels (AST and ALT) regularly. This emerging research on food peptides is interesting but not yet a treatment option.
Want to Apply This Research?
- Track liver health markers (AST and ALT levels from blood tests) every 3-6 months if you have liver disease or risk factors. Log these results in the app to monitor trends over time and share with your healthcare provider.
- While waiting for human studies, users could log their protein intake sources and note any changes in energy levels or digestive health. This creates a personal baseline for future comparison if functional foods based on this research become available.
- Set quarterly reminders to review liver enzyme test results with your doctor. Use the app to track overall dietary patterns, including protein sources, to maintain awareness of nutritional choices. When and if products based on this research become available, the app could help users track consumption and any perceived health changes.
This article summarizes preliminary research conducted in laboratory and animal models. The findings have not been tested in humans and should not be used as medical advice. Jinhua ham has not been approved as a treatment for liver disease. If you have liver disease, nonalcoholic fatty liver disease, or concerns about liver health, consult your healthcare provider about evidence-based treatment options. Do not change your diet or supplement routine based on this research without professional medical guidance. This article is for educational purposes only and does not constitute medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.